The Secondary Prevention of Stroke in Patients With Atrial Fibrillation
Dominique Deplanque
Archives of Neurology, 1986
View PDFchevron_right
Effects of low-dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation
Nils Edvardsson
Journal of Internal Medicine, 2003
View PDFchevron_right
Atrial fibrillation, is warfarin the only option for stroke prevention?
Maria Khan
JPMA. The Journal of the Pakistan Medical Association, 2011
View PDFchevron_right
Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation* *Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology
Rodney Falk
Journal of the American College of Cardiology, 2004
View PDFchevron_right
Current status of stroke prevention in patients with atrial fibrillation
Philip M Bath
European Heart Journal Supplements, 2005
View PDFchevron_right
Immediate and Long-term Prevention of Thromboembolism in Atrial Fibrillation (AF)
Joseph Blackshear
1999
View PDFchevron_right
Low-Intensity Warfarin Therapy for the Prevention of Stroke in Patients with High-Risk Nonvalvular Atrial Fibrillation
Jaw-wen Chen
View PDFchevron_right
Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation
Vittorio Pengo
The American Journal of Cardiology, 1998
View PDFchevron_right
Stroke prevention in atrial fibrillation
Tatjana Rundek
BMJ, 1997
View PDFchevron_right
Warfarin for atrial fibrillation: the end of an era?
Helen Dewey
The Lancet Neurology, 2004
View PDFchevron_right
Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation : A Multicenter, Prospective, Randomized Trial
Takenori Yamaguchi
Stroke, 2000
View PDFchevron_right
Mixed Treatment Comparison Meta-Analysis of Aspirin, Warfarin, and New Anticoagulants for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation
Jennifer Donovan, Matthew Silva
Clinical Therapeutics, 2013
View PDFchevron_right
Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269
Joy Rahman
BMC Cardiovascular Disorders, 2003
View PDFchevron_right
Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry
HIDEKI ORIGASA
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2015
View PDFchevron_right
Design of a multicenter randomized trial for the Stroke Prevention in Atrial Fibrillation Study. The Stroke Prevention in Atrial Fibrillation Investigators
Robert Chahine
Stroke, 1990
View PDFchevron_right
A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)
robin portner
Age and Ageing, 2007
View PDFchevron_right
Differential Use of Warfarin for Secondary Stroke Prevention in Patients With Various Types of Atrial Fibrillation
Wenqin Pan
The American Journal of Cardiology, 2009
View PDFchevron_right
Preventing stroke in people with atrial fibrillation: a cross-sectional study
Lavanya Thana
Journal of public health (Oxford, England), 2005
View PDFchevron_right
The morbidity related to atrial fibrillation at a tertiary centre in one year: 9.0% of all strokes are potentially preventable
Andrew Evans
View PDFchevron_right
A Patient Decision Aid Regarding Antithrombotic Therapy for Stroke Prevention in Atrial FibrillationA Randomized Controlled Trial
Elizabeth Yetisir
JAMA, 1999
View PDFchevron_right
Risk factors for stroke and primary prevention of stroke in atrial fibrillation
Daniel Singer
Journal of Thrombosis …, 1999
View PDFchevron_right
fibrillation Reconsidering combined antiplatelet and anticoagulant therapy in atrial
Rodney Falk
2010
View PDFchevron_right
Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?
Peter Zimetbaum
The American Journal of Medicine, 2010
View PDFchevron_right
Rates of Ischemic Stroke During Warfarin Treatment for Atrial Fibrillation
Michael Paterson
Stroke; a journal of cerebral circulation, 2015
View PDFchevron_right
Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation
G. Amabile
Stroke, 1997
View PDFchevron_right
Warfarin use in atrial fibrillation patients at low risk for stroke: analysis of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2)
Brian Haymart, Jay Kozlowski, Steve Almany, Julia Winfield
Journal of Thrombosis and Thrombolysis, 2014
View PDFchevron_right
A Patient Decision Aid Regarding Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation
Elizabeth Yetisir
2000
View PDFchevron_right
New Anticoagulants for Atrial Fibrillation: The Beginning of a A New Era in Stroke Prevention
Jafna Cox
The Canadian Journal of Neurological Sciences, 2011
View PDFchevron_right
Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?
Jonathan Plumb
Journal of Thrombosis and Haemostasis, 2008
View PDFchevron_right
Outcomes in the management of atrial fibrillation: clinical trial results can apply in practice
Shane Jackson
Internal Medicine Journal, 2001
View PDFchevron_right
Stroke Prevention in Atrial Fibrillation: Managing the Risks in Light of New Oral Anticoagulants
John Strobeck
Cardiovascular Drugs and Therapy, 2012
View PDFchevron_right
Alternatives to Warfarin for Thromboembolism Prophylaxis in Nonrheumatic Atrial Fibrillation
Ramin Artang
Journal of Interventional Cardiac Electrophysiology, 2004
View PDFchevron_right
Low-Dose Aspirin for Prevention of Stroke in Low-Risk Patients With Atrial Fibrillation
HIDEKI ORIGASA
Stroke, 2005
View PDFchevron_right
The Increasing Need for Anticoagulant Therapy to Prevent Stroke in Patients With Atrial Fibrillation
Rodney Falk
Mayo Clinic Proceedings, 2004
View PDFchevron_right